J Van De Sande - JoVE Visualize

Showing results (171-180 of 323) with videos related to

Pageof 33

Sort By:

Plos Neglected Tropical Diseases|January 16, 2020

Madurella real-time PCR, a novel approach for eumycetoma diagnosisAmir Arastehfar, Wilson Lim, Farnaz Daneshnia, et al.

Mycoses|August 25, 2022

Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetomaBertrand Nyuykonge, Emmanuel E Siddig, Najwa Adam Mhmoud, et al.

The Bone & Joint Journal|April 1, 2021

Management of tenosynovial giant cell tumour of the foot and ankleGeert Spierenburg, Sarah Tamar Lancaster, Lizz van der Heijden, et al.

Annals of Surgical Oncology|May 10, 2021

Management of Soft Tissue Sarcomas in Extremities: Variation in Treatment Recommendations and Surveillance According to Specialty and ContinentIbtissam Acem, Merel M Smit, Cornelis Verhoef, et al.

Antimicrobial Agents and Chemotherapy|June 25, 2004

In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assayAbdalla O A Ahmed, Wendy W J van de Sande, Wim van Vianen, et al.

Bone & Joint Open|June 15, 2025

Proximal humeral endoprosthetic reconstruction for tumour defects : clinical outcomes of 165 patients from the MUTARS Orthopedic Registry Orthopedic Registry Europe (MORE)Richard Evenhuis, Michaël P A Bus, Simen Sellevold, et al.

Plos One|October 25, 2013

Evidence supporting a role for mammalian chitinases in efficacy of caspofungin against experimental aspergillosis in immunocompromised ratsPatricia E B Verwer, Marian T ten Kate, Franco H Falcone, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006

Translationally controlled tumor protein from Madurella mycetomatis, a marker for tumorous mycetoma progressionWendy W J van de Sande, Dirk-Jan Janse, Vishal Hira, et al.

Antimicrobial Agents and Chemotherapy|February 25, 2009

Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafunginWendy W J van de Sande, Ron A A Mathot, Marian T ten Kate, et al.

Transactions of the Royal Society of Tropical Medicine and Hygiene|December 31, 2020

Human actinomycetoma caused by Actinomadura mexicana in Sudan: the first reportEmmanuel Edwar Siddig, Bertrand Nyuykonge, Mohammed Tayfour Ahmed, et al.

Pageof 33

Showing results (171-180 of 323) with videos related to

Sort By:

Pageof 33

Plos Neglected Tropical Diseases|January 16, 2020

Madurella real-time PCR, a novel approach for eumycetoma diagnosisAmir Arastehfar, Wilson Lim, Farnaz Daneshnia, et al.

Mycoses|August 25, 2022

Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetomaBertrand Nyuykonge, Emmanuel E Siddig, Najwa Adam Mhmoud, et al.

The Bone & Joint Journal|April 1, 2021

Management of tenosynovial giant cell tumour of the foot and ankleGeert Spierenburg, Sarah Tamar Lancaster, Lizz van der Heijden, et al.

Annals of Surgical Oncology|May 10, 2021

Management of Soft Tissue Sarcomas in Extremities: Variation in Treatment Recommendations and Surveillance According to Specialty and ContinentIbtissam Acem, Merel M Smit, Cornelis Verhoef, et al.

Antimicrobial Agents and Chemotherapy|June 25, 2004

In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assayAbdalla O A Ahmed, Wendy W J van de Sande, Wim van Vianen, et al.

Bone & Joint Open|June 15, 2025

Proximal humeral endoprosthetic reconstruction for tumour defects : clinical outcomes of 165 patients from the MUTARS Orthopedic Registry Orthopedic Registry Europe (MORE)Richard Evenhuis, Michaël P A Bus, Simen Sellevold, et al.

Plos One|October 25, 2013

Evidence supporting a role for mammalian chitinases in efficacy of caspofungin against experimental aspergillosis in immunocompromised ratsPatricia E B Verwer, Marian T ten Kate, Franco H Falcone, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006

Translationally controlled tumor protein from Madurella mycetomatis, a marker for tumorous mycetoma progressionWendy W J van de Sande, Dirk-Jan Janse, Vishal Hira, et al.

Antimicrobial Agents and Chemotherapy|February 25, 2009

Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafunginWendy W J van de Sande, Ron A A Mathot, Marian T ten Kate, et al.

Transactions of the Royal Society of Tropical Medicine and Hygiene|December 31, 2020

Human actinomycetoma caused by Actinomadura mexicana in Sudan: the first reportEmmanuel Edwar Siddig, Bertrand Nyuykonge, Mohammed Tayfour Ahmed, et al.

Pageof 33